Physician profile
Robert W Nelson
NPI 1083931877
$958.30
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $369 · 2021: $152 · 2022: $296.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $197.97 | 2020-2022 | |
| Abbvie INC. | $143.25 | 2022 | |
| Allergan, INC. | $133.06 | 2019-2022 | |
| Amgen INC. | $58.56 | 2019-2022 | |
| Lundbeck LLC | $45.79 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $43.46 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $42.44 | 2020 | |
| Emd Serono, INC. | $41.39 | 2019-2020 | |
| Ucb, INC. | $38.60 | 2019-2021 | |
| Genzyme Corporation | $30.62 | 2019-2020 | |
| Biogen, INC. | $28.24 | 2020-2021 | |
| Lilly USA, LLC | $22.79 | 2019 | |
| Celgene Corporation | $22.70 | 2020 | |
| Csl Behring | $21.67 | 2022 | |
| Eisai INC. | $21.01 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $19.44 | 2020 | |
| Upsher-Smith Laboratories LLC | $19.32 | 2020 | |
| Adamas Pharmaceuticals, INC. | $16.09 | 2021 | |
| Neurocrine Biosciences, INC. | $11.90 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.